What is Nexgel Inc's earnings per share (EPS)?

Nexgel Inc (NXGL) reported diluted earnings per share of $-0.38 for fiscal year 2025. This represents a 24.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Nexgel Inc Financials

NXGL

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE March

This page shows Nexgel Inc (NXGL) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Earnings Quality Low Quality

0.44x

For every $1 of reported earnings, Nexgel Inc generates $0.44 in operating cash flow (-$1.3M OCF vs -$3.0M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

-98.6x

Nexgel Inc earns $-98.6 in operating income for every $1 of interest expense (-$3.4M vs $34K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$11.4M

YoY+31.5%

5Y CAGR+76.1%

Nexgel Inc generated $11.4M in revenue in fiscal year 2025. This represents an increase of 31.5% from the prior year.

EBITDA

-$2.9M

YoY+6.9%

Nexgel Inc's EBITDA was -$2.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 6.9% from the prior year.

Net Income

-$3.0M

YoY+8.6%

Nexgel Inc reported -$3.0M in net income in fiscal year 2025. This represents an increase of 8.6% from the prior year.

EPS (Diluted)

$-0.38

YoY+24.0%

Nexgel Inc earned $-0.38 per diluted share (EPS) in fiscal year 2025. This represents an increase of 24.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$1.4M

YoY+68.0%

Nexgel Inc generated -$1.4M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 68.0% from the prior year.

Cash & Debt

N/A

Dividends Per Share

N/A

Shares Outstanding

YoY+11.0%

Nexgel Inc had 8M shares outstanding in fiscal year 2025. This represents an increase of 11.0% from the prior year.

Margins & Returns

Gross Margin

39.5%

YoY+7.8pp

5Y CAGR+82.7pp

Nexgel Inc's gross margin was 39.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 7.8 percentage points from the prior year.

Operating Margin

-29.3%

YoY+11.6pp

5Y CAGR+306.0pp

Nexgel Inc's operating margin was -29.3% in fiscal year 2025, reflecting core business profitability. This is up 11.6 percentage points from the prior year.

Net Margin

-26.3%

YoY+11.5pp

5Y CAGR+309.6pp

Nexgel Inc's net profit margin was -26.3% in fiscal year 2025, showing the share of revenue converted to profit. This is up 11.5 percentage points from the prior year.

Return on Equity

N/A

Capital Allocation

R&D Spending

$2K

YoY-97.4%

Nexgel Inc invested $2K in research and development in fiscal year 2025. This represents a decrease of 97.4% from the prior year.

Share Buybacks

N/A

Capital Expenditures

$68K

YoY-84.7%

5Y CAGR-26.3%

Nexgel Inc invested $68K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 84.7% from the prior year.

NXGL Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$11.4M+31.5%	$8.7M+112.5%	$4.1M+99.7%	$2.0M+32.0%	$1.6M+130.1%	$674K
Cost of Revenue	$6.9M+16.4%	$5.9M+59.9%	$3.7M+107.3%	$1.8M+16.1%	$1.5M+59.9%	$965K
Gross Profit	$4.5M+64.1%	$2.7M+634.8%	$374K+46.1%	$256K+3100.0%	$8K+102.7%	-$291K
R&D Expenses	$2K-97.4%	$78K-24.3%	$103K-71.9%	$367K+1083.9%	$31K	N/A
SG&A Expenses	$7.9M+26.3%	$6.2M+66.1%	$3.7M+15.8%	$3.2M+27.1%	$2.5M+29.4%	$2.0M
Operating Income	-$3.4M+5.7%	-$3.6M-2.2%	-$3.5M-3.9%	-$3.3M-30.3%	-$2.6M-13.7%	-$2.3M
Interest Expense	$34K-58.0%	$81K+440.0%	$15K-98.9%	$1.3M	N/A	N/A
Income Tax	N/A	N/A	N/A	$0	$0	$0
Net Income	-$3.0M+8.6%	-$3.3M-3.9%	-$3.2M+33.5%	-$4.7M-10.1%	-$4.3M-90.4%	-$2.3M
EPS (Diluted)	$-0.38+24.0%	$-0.50+10.7%	$-0.56+34.1%	$-0.85+41.4%	$-1.45	$-1.05

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	$2.9M+1.7%	$2.9M+2.8%	$2.8M-7.8%	$3.0M+3.5%	$2.9M+104.2%	$1.4M+13.7%	$1.3M+17.1%	$1.1M
Cost of Revenue	$1.7M+4.0%	$1.6M+0.5%	$1.6M-14.9%	$1.9M+6.6%	$1.8M+55.6%	$1.1M+3.7%	$1.1M-5.4%	$1.2M
Gross Profit	$1.2M-1.2%	$1.3M+5.9%	$1.2M+4.2%	$1.1M-1.3%	$1.2M+294.2%	$293K+83.1%	$160K+281.8%	-$88K
R&D Expenses	$7K	N/A	$1K	N/A	N/A	$76K+3700.0%	$2K-84.6%	$13K
SG&A Expenses	$2.0M+3.5%	$1.9M-3.6%	$2.0M-0.9%	$2.0M+2.0%	$1.9M+52.9%	$1.3M+23.5%	$1.0M-8.0%	$1.1M
Operating Income	-$725K-14.0%	-$636K+18.1%	-$777K+7.6%	-$841K-6.7%	-$788K+25.2%	-$1.1M-21.0%	-$871K+28.6%	-$1.2M
Interest Expense	N/A	N/A	N/A	$16K-20.0%	$20K-33.3%	$30K+100.0%	$15K+650.0%	$2K
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$653K+1.8%	-$665K+6.6%	-$712K+16.2%	-$850K-22.7%	-$693K+21.7%	-$885K-3.8%	-$853K+22.3%	-$1.1M
EPS (Diluted)	$-0.08+11.1%	$-0.090.0%	$-0.09	N/A	$-0.11+21.4%	$-0.140.0%	$-0.14	N/A

NXGL Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	N/A	$11.0M+10.3%	$10.0M-3.9%	$10.4M-39.0%	$17.0M+652.5%	$2.3M
Current Assets	N/A	$5.1M+1.2%	$5.1M-32.7%	$7.5M-46.1%	$13.9M+3736.6%	$363K
Cash & Equivalents	N/A	$1.8M-33.1%	$2.7M+145.2%	$1.1M-91.8%	$13.3M+41618.8%	$32K
Inventory	N/A	$1.8M+32.8%	$1.3M+162.7%	$502K+72.5%	$291K+24.9%	$233K
Accounts Receivable	N/A	$933K+47.4%	$633K+185.1%	$222K+6.2%	$209K+186.3%	$73K
Goodwill	N/A	$1.1M0.0%	$1.1M+262.7%	$311K0.0%	$311K0.0%	$311K
Total Liabilities	N/A	$4.9M+2.4%	$4.8M+76.1%	$2.7M-44.5%	$4.9M+124.1%	$2.2M
Current Liabilities	N/A	$2.5M-3.1%	$2.5M+196.7%	$859K-70.3%	$2.9M+116.8%	$1.3M
Long-Term Debt	N/A	$685K+15.5%	$593K+109.5%	$283K	N/A	N/A
Total Equity	N/A	$5.8M+22.5%	$4.7M-38.5%	$7.6M-36.8%	$12.1M+16921.1%	$71K
Retained Earnings	N/A	-$18.0M-22.3%	-$14.7M-27.3%	-$11.6M-69.7%	-$6.8M-172.3%	-$2.5M

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$11.6M+19.7%	$9.7M-7.0%	$10.4M-5.0%	$11.0M+3.9%	$10.6M+8.1%	$9.8M-5.9%	$10.4M+4.3%	$10.0M
Current Assets	$5.6M+34.6%	$4.2M-12.2%	$4.7M-7.3%	$5.1M+10.9%	$4.6M+28.5%	$3.6M-26.2%	$4.9M-3.7%	$5.1M
Cash & Equivalents	$938K+29.4%	$725K-39.2%	$1.2M-34.0%	$1.8M+70.6%	$1.1M-0.9%	$1.1M-55.8%	$2.4M-10.4%	$2.7M
Inventory	$2.0M+10.9%	$1.8M-1.4%	$1.8M+5.4%	$1.8M-1.5%	$1.8M+23.0%	$1.4M+5.6%	$1.4M+3.8%	$1.3M
Accounts Receivable	$839K+11.4%	$753K-18.7%	$926K-0.8%	$933K+4.4%	$894K+47.8%	$605K-18.1%	$739K+16.7%	$633K
Goodwill	$1.1M0.0%	$1.1M0.0%	$1.1M0.0%	$1.1M+0.4%	$1.1M-0.4%	$1.1M0.0%	$1.1M0.0%	$1.1M
Total Liabilities	$6.0M+29.8%	$4.7M-4.4%	$4.9M-0.7%	$4.9M-12.2%	$5.6M+6.4%	$5.2M+1.3%	$5.2M+8.2%	$4.8M
Current Liabilities	$3.3M+38.1%	$2.4M-4.9%	$2.5M+2.0%	$2.5M-19.0%	$3.0M+15.8%	$2.6M+6.0%	$2.5M-2.6%	$2.5M
Long-Term Debt	$614K-3.8%	$638K-3.6%	$662K-3.4%	$685K-3.4%	$709K-3.1%	$732K-2.4%	$750K+26.5%	$593K
Total Equity	$5.2M+11.0%	$4.7M-10.3%	$5.2M-9.5%	$5.8M+22.8%	$4.7M+12.5%	$4.2M-13.0%	$4.8M+1.9%	$4.7M
Retained Earnings	-$20.0M-3.4%	-$19.4M-3.6%	-$18.7M-4.0%	-$18.0M-5.0%	-$17.1M-4.2%	-$16.5M-5.7%	-$15.6M-5.8%	-$14.7M

NXGL Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$1.3M+66.1%	-$3.9M-19.5%	-$3.2M-8.2%	-$3.0M-8.7%	-$2.8M-52.9%	-$1.8M
Capital Expenditures	$68K-84.7%	$443K-36.4%	$696K+625.0%	$96K-64.3%	$269K-13.8%	$312K
Free Cash Flow	-$1.4M+68.0%	-$4.3M-9.6%	-$3.9M-27.3%	-$3.1M-2.2%	-$3.0M-43.0%	-$2.1M
Investing Cash Flow	-$68K+91.2%	-$775K-117.4%	$4.5M+179.6%	-$5.6M-1979.9%	-$269K+13.8%	-$312K
Financing Cash Flow	$630K-83.2%	$3.7M+889.2%	$379K+110.3%	-$3.7M-122.4%	$16.3M+767.3%	$1.9M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	-$785K-92.9%	-$407K-1.8%	-$400K+53.4%	-$859K+29.4%	-$1.2M-73.7%	-$700K+35.9%	-$1.1M-86.0%	-$587K
Capital Expenditures	$8K	N/A	N/A	$69K+430.8%	$13K-93.8%	$209K+37.5%	$152K+78.8%	$85K
Free Cash Flow	-$793K	N/A	N/A	-$928K+24.5%	-$1.2M-35.2%	-$909K+26.9%	-$1.2M-85.1%	-$672K
Investing Cash Flow	-$8K	N/A	N/A	-$63K-687.5%	-$8K+98.6%	-$586K-396.6%	-$118K+56.8%	-$273K
Financing Cash Flow	$1.9M+4915.0%	-$40K+81.4%	-$215K-112.9%	$1.7M+37.6%	$1.2M+1996.9%	-$64K-106.9%	$929K+216.0%	$294K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

NXGL Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	39.5%+7.8pp	31.6%+22.5pp	9.2%-3.4pp	12.5%+12.0pp	0.5%+43.7pp	-43.2%
Operating Margin	-29.3%+11.6pp	-40.9%+44.1pp	-85.0%+78.5pp	-163.5%+2.2pp	-165.7%+169.6pp	-335.3%
Net Margin	-26.3%+11.5pp	-37.8%+39.5pp	-77.2%+154.5pp	-231.7%+46.2pp	-277.9%+58.0pp	-335.9%
Return on Equity	N/A	-57.0%+10.2pp	-67.2%-5.1pp	-62.1%-26.5pp	-35.7%+3153.1pp	-3188.7%
Return on Assets	N/A	-29.9%+1.8pp	-31.7%+14.1pp	-45.8%-20.4pp	-25.4%+74.9pp	-100.3%
Current Ratio	N/A	2.07+0.1	1.98-6.8	8.74+3.9	4.82+4.5	0.27
Debt-to-Equity	N/A	0.120.0	0.13+0.1	0.04-0.4	0.41-30.4	30.79
FCF Margin	-12.1%+37.5pp	-49.6%+46.6pp	-96.2%+54.6pp	-150.8%+44.1pp	-194.8%+118.7pp	-313.5%

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Gross Margin	42.4%-1.2pp	43.6%+1.3pp	42.3%+4.9pp	37.5%-1.8pp	39.3%+18.9pp	20.3%+7.7pp	12.6%+20.8pp	-8.1%
Operating Margin	-24.7%-2.7pp	-22.1%+5.6pp	-27.7%-0.0pp	-27.7%-0.9pp	-26.8%+46.4pp	-73.2%-4.4pp	-68.8%+44.1pp	-112.9%
Net Margin	-22.3%+0.8pp	-23.1%+2.3pp	-25.4%+2.6pp	-27.9%-4.4pp	-23.6%+37.9pp	-61.5%+5.9pp	-67.4%+34.2pp	-101.6%
Return on Equity	-12.6%+1.6pp	-14.2%-0.6pp	-13.7%+1.1pp	-14.8%+0.0pp	-14.8%+6.5pp	-21.2%-3.4pp	-17.8%+5.6pp	-23.4%
Return on Assets	-5.6%+1.2pp	-6.9%-0.0pp	-6.8%+0.9pp	-7.7%-1.2pp	-6.6%+2.5pp	-9.0%-0.8pp	-8.2%+2.8pp	-11.0%
Current Ratio	1.69-0.0	1.74-0.1	1.88-0.2	2.07+0.6	1.51+0.1	1.36-0.6	1.96-0.0	1.98
Debt-to-Equity	0.12-0.0	0.140.0	0.130.0	0.12-0.0	0.15-0.0	0.18+0.0	0.16+0.0	0.13
FCF Margin	-27.0%	N/A	N/A	-30.5%+11.3pp	-41.8%+21.3pp	-63.1%+35.1pp	-98.3%-36.1pp	-62.2%

Similar Companies

Harvard Biosci HBIO

$23.3M

Retractable Tech RVP

$20.6M

Bionano Genomics Inc BNGO

$13.3M

Precision Optics POCI

$46.7M

Meihua International Medical Technologies Co., Ltd. MHUA

$425.4M

Frequently Asked Questions

What is Nexgel Inc's annual revenue?

Nexgel Inc (NXGL) reported $11.4M in total revenue for fiscal year 2025. This represents a 31.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Nexgel Inc's revenue growing?

Nexgel Inc (NXGL) revenue grew by 31.5% year-over-year, from $8.7M to $11.4M in fiscal year 2025.

Is Nexgel Inc profitable?

No, Nexgel Inc (NXGL) reported a net income of -$3.0M in fiscal year 2025, with a net profit margin of -26.3%.

What is Nexgel Inc's EBITDA?

Nexgel Inc (NXGL) had EBITDA of -$2.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Nexgel Inc's gross margin?

Nexgel Inc (NXGL) had a gross margin of 39.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Nexgel Inc's operating margin?

Nexgel Inc (NXGL) had an operating margin of -29.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Nexgel Inc's net profit margin?

Nexgel Inc (NXGL) had a net profit margin of -26.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Nexgel Inc's free cash flow?

Nexgel Inc (NXGL) generated -$1.4M in free cash flow during fiscal year 2025. This represents a 68.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Nexgel Inc's operating cash flow?

Nexgel Inc (NXGL) generated -$1.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Nexgel Inc's capital expenditures?

Nexgel Inc (NXGL) invested $68K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Nexgel Inc spend on research and development?

Nexgel Inc (NXGL) invested $2K in research and development during fiscal year 2025.

How many shares does Nexgel Inc have outstanding?

Nexgel Inc (NXGL) had 8M shares outstanding as of fiscal year 2025.

Are Nexgel Inc's earnings high quality?

Nexgel Inc (NXGL) has an earnings quality ratio of 0.44x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Nexgel Inc cover its interest payments?

Nexgel Inc (NXGL) has an interest coverage ratio of -98.6x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.